Back
Cullinan Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
42
CGEM
Cullinan Therapeutics, Inc.
Last Price:
$10.33
Seasonality Move:
11%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is relatively stagnant and CGEM is experiencing selling pressure, which indicates risk of future bearish movement.
Cullinan Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 10.88 | Sell |
| 20-day SMA: | 11.09 | Sell |
| 50-day SMA: | 9.26 | Buy |
| 200-day SMA: | 8.09 | Buy |
| 8-day EMA: | 10.47 | Sell |
| 20-day EMA: | 10.5 | Sell |
| 50-day EMA: | 9.52 | Buy |
| 200-day EMA: | 9.07 | Buy |
Cullinan Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.32 | Buy |
| Relative Strength Index (14 RSI): | 45.56 | Sell |
| Chaikin Money Flow: | -1376235 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.21 - 11.97) | Sell |
| Bollinger Bands (100): | (6.35 - 9.85) | Buy |
Cullinan Therapeutics, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Cullinan Therapeutics, Inc. Stock
Is Cullinan Therapeutics, Inc. Stock a Buy?
-
Cullinan Therapeutics, Inc. share price is 9.68 while CGEM 8-day simple moving average is 10.88, which is a Sell signal.
-
The stock price of CGEM is 9.68 while Cullinan Therapeutics, Inc. 20-day SMA is 11.09, which makes it a Sell.
-
Cullinan Therapeutics, Inc. 50-day simple moving average is 9.26 while CGEM share price is 9.68, making it a Buy technically.
-
CGEM stock price is 9.68 and Cullinan Therapeutics, Inc. 200-day simple moving average is 8.09, creating a Buy signal.
CGEM Technical Analysis vs Fundamental Analysis
Sell
42
Cullinan Therapeutics, Inc. (CGEM)
is a Sell
Is Cullinan Therapeutics, Inc. a Buy or a Sell?
-
Cullinan Therapeutics, Inc. stock is rated a SellThe current Cullinan Therapeutics, Inc. [CGEM] share price is $9.68. The Score for CGEM is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
Cullinan Therapeutics, Inc. Stock Info
Market Cap:
571.9M
Price in USD:
9.68
Share Volume:
1.9M
Cullinan Therapeutics, Inc. 52-Week Range
52-Week High:
13.33
52-Week Low:
5.68
Sell
42
Cullinan Therapeutics, Inc. (CGEM)
is a Sell
Cullinan Therapeutics, Inc. Share Price Forecast
-
What is the Cullinan Therapeutics, Inc. stock price today?The Cullinan Therapeutics, Inc. stock price is 9.68 USD today.
-
Will CGEM stock go up or go down?Cullinan Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Cullinan Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cullinan Therapeutics, Inc. is overvalued.
Is Cullinan Therapeutics, Inc. Stock a Buy?
-
Cullinan Therapeutics, Inc. share price is 9.68 while CGEM 8-day exponential moving average is 10.47, which is a Sell signal.
-
The stock price of CGEM is 9.68 while Cullinan Therapeutics, Inc. 20-day EMA is 10.50, which makes it a Sell.
-
Cullinan Therapeutics, Inc. 50-day exponential moving average is 9.52 while CGEM share price is 9.68, making it a Buy technically.
-
CGEM stock price is 9.68 and Cullinan Therapeutics, Inc. 200-day simple moving average is 9.07, creating a Buy signal.
Fundamental Analysis of Cullinan Therapeutics, Inc.
Is Cullinan Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.67 per share, and an increase next year of $0.29 per share.
Technical Analysis of Cullinan Therapeutics, Inc.
Should I short Cullinan Therapeutics, Inc. stock?
-
CGEM Moving Average Covergence Divergence (MACD) indicator is 0.32, suggesting Cullinan Therapeutics, Inc. is a Buy
-
Cullinan Therapeutics, Inc. Relative Strength Index (RSI) is 45.56, which suggest Cullinan Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for Cullinan Therapeutics, Inc. is (9.21 - 11.97), which suggest Cullinan Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Cullinan Therapeutics, Inc. is (6.35 - 9.85), which suggest Cullinan Therapeutics, Inc. is a Buy
* Cullinan Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.